The utility of these taxa in promoting metabolic health directly has been explored via probiotic potential; supplementation with D. newyorkensis has demonstrated improved endothelial function in mice [57,58], and clinical trials with A. muciniphila have shown improvement in markers of MetS including insulin sensitivity and hypercholesterolemia [11,59,60]. This evidence concerns the gene INS and familial hypercholesterolemia.